These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3276315)

  • 1. Structure-activity relationships in the beta-lactam family: an impossible dream.
    Frère JM; Joris B; Varetto L; Crine M
    Biochem Pharmacol; 1988 Jan; 37(1):125-32. PubMed ID: 3276315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity of Escherichia coli to various beta-lactams is determined by the interplay of outer membrane permeability and degradation by periplasmic beta-lactamases: a quantitative predictive treatment.
    Nikaido H; Normark S
    Mol Microbiol; 1987 Jul; 1(1):29-36. PubMed ID: 3330755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outer membrane permeability of imipenem in comparison with other beta-lactam antibiotics.
    Hashizume T; Yamaguchi A; Sawai T
    J Antibiot (Tokyo); 1986 Jan; 39(1):153-6. PubMed ID: 3512504
    [No Abstract]   [Full Text] [Related]  

  • 4. Diversity of the mechanisms of resistance to beta-lactam antibiotics.
    Frère JM; Joris B; Granier B; Matagne A; Jacob F; Bourguignon-Bellefroid C
    Res Microbiol; 1991; 142(6):705-10. PubMed ID: 1961980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffusion of beta-lactam antibiotics through oligomeric or monomeric porin channels of some gram-negative bacteria.
    Nitzan Y; Deutsch EB; Pechatnikov I
    Curr Microbiol; 2002 Dec; 45(6):446-55. PubMed ID: 12402087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relations of 5,6-cis carbapenem antibiotics and role of factors determining susceptibility of Escherichia coli to beta-lactam antibiotics.
    Nozaki Y; Harada S; Kitano K; Imada A
    J Antibiot (Tokyo); 1984 Mar; 37(3):218-26. PubMed ID: 6373699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative relationship between sensitivity to beta-lactam antibiotics and beta-lactamase production in gram-negative bacteria--I. Steady-state treatment.
    Frère JM
    Biochem Pharmacol; 1989 May; 38(9):1415-26. PubMed ID: 2785796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An explicit model for bacterial resistance: application to beta-lactam antibiotics.
    Waley SG
    Microbiol Sci; 1987 May; 4(5):143-6. PubMed ID: 3153188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of beta-lactamases and the permeability barrier in resistance to beta-lactam antibiotics].
    Perduca M; Pagani L; Romero E
    Boll Ist Sieroter Milan; 1985; 64(4):281-4. PubMed ID: 3935134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Penetration through the gram-negative cell wall: a co-determinant of the efficacy of beta-lactam antibiotics.
    Zimmermann W
    Int J Clin Pharmacol Biopharm; 1979 Mar; 17(3):131-4. PubMed ID: 107128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mechanism of action of beta-lactam antibiotics and the resistance of microorganisms].
    Vakulenko SB
    Antibiot Med Biotekhnol; 1987 Apr; 32(4):294-302. PubMed ID: 3307609
    [No Abstract]   [Full Text] [Related]  

  • 12. Contribution of the cell-surface-associated enzyme in the Zimmermann-Rosselet assay of outer membrane permeability of beta-lactam antibiotics.
    Liu W; Nikaido H
    Antimicrob Agents Chemother; 1991 Jan; 35(1):177-9. PubMed ID: 2014974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of beta-lactamases against beta-lactams.
    Stratton CW
    J Antimicrob Chemother; 1988 Jul; 22 Suppl A():23-35. PubMed ID: 3062002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Permeability to beta-lactams in Bacteroides fragilis.
    Cuchural GJ; Hurlbut S; Malamy MH; Tally FP
    J Antimicrob Chemother; 1988 Dec; 22(6):785-90. PubMed ID: 3266619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mechanisms of microorganism resistance to beta-lactam antibiotics].
    D'iachkova VS; Bazhukova TA
    Zh Mikrobiol Epidemiol Immunobiol; 2014; (4):101-9. PubMed ID: 25286539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations affecting the resistance of Escherichia coli K-12 to beta-lactam antibiotics.
    Hrebenda J; Heleszko H
    J Antimicrob Chemother; 1985 Aug; 16(2):149-56. PubMed ID: 3905746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. beta-Lactamases and susceptibility to beta-lactam antibiotics in Escherichia coli.
    Wu PJ; Shannon K; Phillips I
    J Antimicrob Chemother; 1992 Dec; 30(6):868-71. PubMed ID: 1344881
    [No Abstract]   [Full Text] [Related]  

  • 18. [Bacterial resistance against beta-lactam antibiotics].
    Andersen BM
    Tidsskr Nor Laegeforen; 1990 Oct; 110(25):3233-9. PubMed ID: 2256036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mechanism of susceptibility and resistance of bacteria to beta-lactam antibiotics].
    Tsuji A
    Nihon Rinsho; 1991 Oct; 49(10):2254-60. PubMed ID: 1749080
    [No Abstract]   [Full Text] [Related]  

  • 20. N-Formimidoyl thienamycin (MK0787): in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics.
    Hanslo D; King A; Shannon K; Warren C; Phillips I
    J Antimicrob Chemother; 1981 Jun; 7(6):607-17. PubMed ID: 6265426
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.